BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32703312)

  • 1. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
    Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
    Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
    Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
    Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application.
    Berbís MÁ; Godino FP; Rodríguez-Comas J; Nava E; García-Figueiras R; Baleato-González S; Luna A
    Abdom Radiol (NY); 2024 Jan; 49(1):322-340. PubMed ID: 37889265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative MR imaging biomarkers for distinguishing inflammatory pancreatic mass and pancreatic cancer-a systematic review and meta-analysis.
    Wang ZH; Zhu L; Xue HD; Jin ZY
    Eur Radiol; 2024 Apr; ():. PubMed ID: 38639911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head.
    Ruan Z; Jiao J; Min D; Qu J; Li J; Chen J; Li Q; Wang C
    Oncol Lett; 2018 Jun; 15(6):9735-9744. PubMed ID: 29805684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic congenital anomalies and their features on CT and MR imaging: a pictorial review.
    Amseian G; Ayuso JR
    Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38478039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in the evaluation and management of acute pancreatitis: a review of current practices and future directions.
    Nikpanah M; Morgan DE
    Clin Imaging; 2024 Mar; 107():110086. PubMed ID: 38262258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreas image mining: a systematic review of radiomics.
    Abunahel BM; Pontre B; Kumar H; Petrov MS
    Eur Radiol; 2021 May; 31(5):3447-3467. PubMed ID: 33151391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
    Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
    Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic pancreatitis.
    Beyer G; Habtezion A; Werner J; Lerch MM; Mayerle J
    Lancet; 2020 Aug; 396(10249):499-512. PubMed ID: 32798493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma.
    Rhee H; Park MS
    Korean J Radiol; 2021 Jan; 22(1):23-40. PubMed ID: 32901458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical enhanced computed tomography signs of pancreatic cancer and its differential diagnosis from autoimmune pancreatitis.
    Zhao Y; Li F; An N; Peng Z
    Gland Surg; 2021 Jan; 10(1):347-354. PubMed ID: 33633991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
    Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
    Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic pancreatitis : Characterization and differentiation from pancreatic cancer].
    Kristic A; Bastati N; Poetter-Lang S; Messner A; Herold A; Tamandl D; Ba-Ssalamah A
    Radiologe; 2021 Jun; 61(6):563-571. PubMed ID: 34002282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma.
    Gong XH; Xu JR; Qian LJ
    Abdom Radiol (NY); 2021 Sep; 46(9):4226-4237. PubMed ID: 33914139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Ductal Adenocarcinoma.
    Dhillon J; Betancourt M
    Monogr Clin Cytol; 2020; 26():74-91. PubMed ID: 32987385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of
    Arnone A; Laudicella R; Caobelli F; Guglielmo P; Spallino M; Abenavoli E; Martini AL; Filice R; Comis AD; Cuzzocrea M; Linguanti F; Evangelista L; Alongi P
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33287195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of immunohistochemistry for IgG4 in the diagnosis of autoimmune pancreatitis: A systematic review and meta-analysis.
    Yoon SB; Moon SH; Kim JH; Song TJ; Kim MH
    Pancreatology; 2020 Dec; 20(8):1611-1619. PubMed ID: 33060017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Autoimmune Pancreatitis: A Simple Flow Chart for a Challenging Diagnosis.
    Conti CB; Cereatti F; Drago A; Grassia R
    Ultrasound Int Open; 2020 Dec; 6(3):E67-E75. PubMed ID: 33490857
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.